December 20 (SeeNews) - Bulgarian pharmaceuticals producer Sopharma [BUL:SFA] said on Wednesday that its sales revenue grew by an annual 14% in the eleven months through November, mostly due to higher exports.
Revenue from export sales increased by 21% on the year in January-November, while sales on the domestic market rose by 3%, Sopharma said in a bourse filing.
In November alone, Sopharma's sales revenue dropped by 20% year-on-year. The company's export sales declined by an annual 26% last month, while domestic sales fell by 11%.
As of 1330 CET on Wednesday, shares in Sopharma traded 0.34% lower at 5.86 levs ($3.28/3.00 euro) on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)